vs
优尼威尔（DSGR）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
优尼威尔的季度营收约是LifeStance Health Group, Inc.的1.4倍（$518.0M vs $382.2M），LifeStance Health Group, Inc.净利率更高（3.1% vs 1.2%，领先1.8%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 10.7%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $32.9M），过去两年优尼威尔的营收复合增速更高（13.1% vs 12.8%）
优尼威尔解决方案公司是一家全球化化学品与原料分销商，同时可为客户提供各类增值服务，业务网络覆盖全球多个地区，在化工及原料分销领域拥有丰富的行业经验与资源积累。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
DSGR vs LFST — 直观对比
营收规模更大
DSGR
是对方的1.4倍
$382.2M
营收增速更快
LFST
高出6.8%
10.7%
净利率更高
LFST
高出1.8%
1.2%
自由现金流更多
LFST
多$13.8M
$32.9M
两年增速更快
DSGR
近两年复合增速
12.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $518.0M | $382.2M |
| 净利润 | $6.5M | $11.7M |
| 毛利率 | 32.9% | — |
| 营业利润率 | 4.6% | 4.7% |
| 净利率 | 1.2% | 3.1% |
| 营收同比 | 10.7% | 17.4% |
| 净利润同比 | -70.6% | 264.1% |
| 每股收益（稀释后） | $0.14 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DSGRLFST
| Q4 25 | — | $382.2M | ||
| Q3 25 | $518.0M | $363.8M | ||
| Q2 25 | $502.4M | $345.3M | ||
| Q1 25 | $478.0M | $333.0M | ||
| Q4 24 | $480.5M | $325.5M | ||
| Q3 24 | $468.0M | $312.7M | ||
| Q2 24 | $439.5M | $312.3M | ||
| Q1 24 | $416.1M | $300.4M |
净利润DSGRLFST
| Q4 25 | — | $11.7M | ||
| Q3 25 | $6.5M | $1.1M | ||
| Q2 25 | $5.0M | $-3.8M | ||
| Q1 25 | $3.3M | $709.0K | ||
| Q4 24 | $-25.9M | $-7.1M | ||
| Q3 24 | $21.9M | $-6.0M | ||
| Q2 24 | $1.9M | $-23.3M | ||
| Q1 24 | $-5.2M | $-21.1M |
毛利率DSGRLFST
| Q4 25 | — | — | ||
| Q3 25 | 32.9% | — | ||
| Q2 25 | 33.9% | — | ||
| Q1 25 | 34.3% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 33.9% | — | ||
| Q2 24 | 34.5% | — | ||
| Q1 24 | 34.5% | — |
营业利润率DSGRLFST
| Q4 25 | — | 4.7% | ||
| Q3 25 | 4.6% | 2.0% | ||
| Q2 25 | 5.3% | -0.9% | ||
| Q1 25 | 4.2% | 0.5% | ||
| Q4 24 | 4.2% | 0.3% | ||
| Q3 24 | 4.0% | 0.0% | ||
| Q2 24 | 3.2% | -5.1% | ||
| Q1 24 | 0.7% | -5.6% |
净利率DSGRLFST
| Q4 25 | — | 3.1% | ||
| Q3 25 | 1.2% | 0.3% | ||
| Q2 25 | 1.0% | -1.1% | ||
| Q1 25 | 0.7% | 0.2% | ||
| Q4 24 | -5.4% | -2.2% | ||
| Q3 24 | 4.7% | -1.9% | ||
| Q2 24 | 0.4% | -7.5% | ||
| Q1 24 | -1.3% | -7.0% |
每股收益（稀释后）DSGRLFST
| Q4 25 | — | — | ||
| Q3 25 | $0.14 | — | ||
| Q2 25 | $0.11 | — | ||
| Q1 25 | $0.07 | — | ||
| Q4 24 | $-0.55 | — | ||
| Q3 24 | $0.46 | — | ||
| Q2 24 | $0.04 | — | ||
| Q1 24 | $-0.11 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.2M | $248.6M |
| 总债务越低越好 | $665.5M | $282.8M |
| 股东权益账面价值 | $653.9M | $1.5B |
| 总资产 | $1.8B | $2.2B |
| 负债/权益比越低杠杆越低 | 1.02× | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资DSGRLFST
| Q4 25 | — | $248.6M | ||
| Q3 25 | $69.2M | $203.9M | ||
| Q2 25 | $47.4M | $188.9M | ||
| Q1 25 | $65.4M | $134.3M | ||
| Q4 24 | $66.5M | $154.6M | ||
| Q3 24 | $61.3M | $102.6M | ||
| Q2 24 | $46.8M | $87.0M | ||
| Q1 24 | $73.1M | $49.5M |
总债务DSGRLFST
| Q4 25 | — | $282.8M | ||
| Q3 25 | $665.5M | $284.6M | ||
| Q2 25 | $675.0M | $286.4M | ||
| Q1 25 | $712.4M | $288.2M | ||
| Q4 24 | $693.9M | $290.0M | ||
| Q3 24 | $704.1M | $287.3M | ||
| Q2 24 | $573.7M | $288.0M | ||
| Q1 24 | $535.7M | $288.8M |
股东权益DSGRLFST
| Q4 25 | — | $1.5B | ||
| Q3 25 | $653.9M | $1.5B | ||
| Q2 25 | $649.4M | $1.5B | ||
| Q1 25 | $636.7M | $1.5B | ||
| Q4 24 | $640.5M | $1.4B | ||
| Q3 24 | $680.8M | $1.4B | ||
| Q2 24 | $653.3M | $1.4B | ||
| Q1 24 | $654.7M | $1.4B |
总资产DSGRLFST
| Q4 25 | — | $2.2B | ||
| Q3 25 | $1.8B | $2.1B | ||
| Q2 25 | $1.8B | $2.1B | ||
| Q1 25 | $1.8B | $2.1B | ||
| Q4 24 | $1.7B | $2.1B | ||
| Q3 24 | $1.8B | $2.1B | ||
| Q2 24 | $1.6B | $2.1B | ||
| Q1 24 | $1.5B | $2.1B |
负债/权益比DSGRLFST
| Q4 25 | — | 0.19× | ||
| Q3 25 | 1.02× | 0.19× | ||
| Q2 25 | 1.04× | 0.19× | ||
| Q1 25 | 1.12× | 0.20× | ||
| Q4 24 | 1.08× | 0.20× | ||
| Q3 24 | 1.03× | 0.20× | ||
| Q2 24 | 0.88× | 0.20× | ||
| Q1 24 | 0.82× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $32.9M | $46.6M |
| 自由现金流率自由现金流/营收 | 6.3% | 12.2% |
| 资本支出强度资本支出/营收 | 1.1% | 2.9% |
| 现金转化率经营现金流/净利润 | 5.95× | 4.93× |
| 过去12个月自由现金流最近4个季度 | $92.2M | $110.0M |
8季度趋势，按日历期对齐
经营现金流DSGRLFST
| Q4 25 | — | $57.6M | ||
| Q3 25 | $38.4M | $27.3M | ||
| Q2 25 | $33.3M | $64.4M | ||
| Q1 25 | $-4.8M | $-3.1M | ||
| Q4 24 | $45.7M | $62.3M | ||
| Q3 24 | $-17.3M | $22.7M | ||
| Q2 24 | $21.4M | $44.1M | ||
| Q1 24 | $6.6M | $-21.8M |
自由现金流DSGRLFST
| Q4 25 | — | $46.6M | ||
| Q3 25 | $32.9M | $17.0M | ||
| Q2 25 | $28.7M | $56.6M | ||
| Q1 25 | $-10.4M | $-10.3M | ||
| Q4 24 | $41.1M | $56.0M | ||
| Q3 24 | $-20.5M | $17.7M | ||
| Q2 24 | $18.0M | $39.0M | ||
| Q1 24 | $4.2M | $-26.9M |
自由现金流率DSGRLFST
| Q4 25 | — | 12.2% | ||
| Q3 25 | 6.3% | 4.7% | ||
| Q2 25 | 5.7% | 16.4% | ||
| Q1 25 | -2.2% | -3.1% | ||
| Q4 24 | 8.6% | 17.2% | ||
| Q3 24 | -4.4% | 5.7% | ||
| Q2 24 | 4.1% | 12.5% | ||
| Q1 24 | 1.0% | -9.0% |
资本支出强度DSGRLFST
| Q4 25 | — | 2.9% | ||
| Q3 25 | 1.1% | 2.8% | ||
| Q2 25 | 0.9% | 2.2% | ||
| Q1 25 | 1.2% | 2.2% | ||
| Q4 24 | 1.0% | 1.9% | ||
| Q3 24 | 0.7% | 1.6% | ||
| Q2 24 | 0.8% | 1.6% | ||
| Q1 24 | 0.6% | 1.7% |
现金转化率DSGRLFST
| Q4 25 | — | 4.93× | ||
| Q3 25 | 5.95× | 25.34× | ||
| Q2 25 | 6.66× | — | ||
| Q1 25 | -1.46× | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.79× | — | ||
| Q2 24 | 11.28× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
LFST
暂无分部数据
